Breaking News Instant updates and real-time market news.

GNMSF

Genmab

, JNJ

Johnson & Johnson

$119.24

0.49 (0.41%)

14:05
10/09/16
10/09
14:05
10/09/16
14:05

Genmab gets FDA priority review for daratumumab in relapsed multiple myeloma

Genmab (GNMSF) announced Friday that the U.S. FDA has granted priority review to the supplemental Biologics License Application for the use of daratumumab in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy. The sBLA was submitted by Genmab's licensing partner, Johnson & Johnson's (JNJ) Janssen Biotech. The FDA has assigned a Prescription Drug User Fee Act target date of February 17, 2017 to take a decision on daratumumab in this indication. In addition, the FDA has granted a Standard Review period for the use of daratumumab in combination with pomalidomide and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received at least two prior therapies, with a proteasome inhibitor and an immunomodulatory agent. The PDUFA date for the combination of daratumumab with pomalidomide/dexamethasone is June 17, 2017.

GNMSF

Genmab

JNJ

Johnson & Johnson

$119.24

0.49 (0.41%)

  • 18

    Oct

  • 06

    Nov

GNMSF Genmab

06/21/16
JPMS
06/21/16
INITIATION
JPMS
Neutral
Genmab initiated with a Neutral at JPMorgan
JPMorgan analyst James Quigley started Genmab with a Neutral rating and DK 1,040 price target.
JNJ Johnson & Johnson
$119.24

0.49 (0.41%)

10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.
09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
08/24/16
JEFF
08/24/16
NO CHANGE
Target $210
JEFF
Buy
Cooper Companies estimates raised at Jefferies after doctor survey
Jefferies analyst Anthony Petrone reports that the firm's survey of 52 new optometry practices suggest continued gains in dailies and stable share in monthlies for Cooper Companies (COO) and that Johnson & Johnson's (JNJ) Acuvue Vita is off to slow start. Based on the survey results, and a "significant" foreign exchange tailwind, Petrone raised his estimates for Cooper and increased his price target on the shares to $210 from $190. The firm has a Buy rating on Cooper shares.

TODAY'S FREE FLY STORIES

MNK

Mallinckrodt

$53.72

0.16 (0.30%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Hot Stocks
Mallinckrodt reports results from IV acetaminophen health economic analysis »

Mallinckrodt announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CTIX

Cellceutix

$1.14

-0.045 (-3.80%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Hot Stocks
Cellceutix Phase 2 trial dose escalates in second cohort for Brilacidin »

Cellceutix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$55.99

0.97 (1.76%)

, SFTBF

SoftBank

$62.00

1.93 (3.21%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Recommendations
T-Mobile, SoftBank, Sprint, DISH, AT&T, Verizon analyst commentary  »

T-Mobile price target…

TMUS

T-Mobile

$55.99

0.97 (1.76%)

SFTBF

SoftBank

$62.00

1.93 (3.21%)

S

Sprint

$8.17

0.12 (1.49%)

DISH

DISH

$58.51

1.85 (3.27%)

T

AT&T

$39.35

0.72 (1.86%)

VZ

Verizon

$50.36

0.61 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 13

    Dec

  • 04

    Jan

  • 24

    Jan

NUS

Nu Skin

$51.56

0.05 (0.10%)

07:32
12/07/16
12/07
07:32
12/07/16
07:32
Hot Stocks
Nu Skin announces CEO transition plan »

Nu Skin Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

CAL

Caleres

$33.80

0.28 (0.84%)

07:31
12/07/16
12/07
07:31
12/07/16
07:31
Upgrade
Caleres rating change  »

Caleres upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$113.57

-0.71 (-0.62%)

, CMCSA

Comcast

$68.70

0.02 (0.03%)

07:31
12/07/16
12/07
07:31
12/07/16
07:31
Conference/Events
UBS to hold a conference »

44th Annual Global Media…

SPGI

S&P Global

$113.57

-0.71 (-0.62%)

CMCSA

Comcast

$68.70

0.02 (0.03%)

AMT

American Tower

$100.85

-1.19 (-1.17%)

HSNI

HSN, Inc.

$35.90

-0.2 (-0.55%)

TGNA

TEGNA

$22.63

0.35 (1.57%)

CNSL

Consolidated Communications

LBTYA

Liberty Global

$29.91

0.36 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

TEVA

Teva

$35.03

-2.01 (-5.43%)

, COG

Cabot Oil & Gas

$23.57

-0.06 (-0.25%)

07:30
12/07/16
12/07
07:30
12/07/16
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TEVA

Teva

$35.03

-2.01 (-5.43%)

COG

Cabot Oil & Gas

$23.57

-0.06 (-0.25%)

FTK

Flotek

$13.11

-0.47 (-3.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 03

    Apr

07:30
12/07/16
12/07
07:30
12/07/16
07:30
General news
Treasury Market Outlook: bond yields are several ticks lower globally »

Treasury Market Outlook:…

CBS

CBS

$60.97

0.16 (0.26%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Recommendations
CBS analyst commentary  »

CBS remains a top pick at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

P

Pandora

$13.78

0.41 (3.07%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Recommendations
Pandora analyst commentary  »

Pandora Premium will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$36.81

0.23 (0.63%)

, LVS

Las Vegas Sands

$62.47

1.35 (2.21%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Conference/Events
Bernstein to hold a summit »

3rd Annual Consumer…

LNCE

Snyder's-Lance

$36.81

0.23 (0.63%)

LVS

Las Vegas Sands

$62.47

1.35 (2.21%)

SAP

SAP

$82.99

-0.14 (-0.17%)

TSN

Tyson Foods

$57.39

0.12 (0.21%)

TUP

Tupperware Brands

$55.46

0.24 (0.43%)

CDXC

ChromaDex

$2.39

0.05 (2.14%)

TVIA

Tvia, Inc.

$1.25

0.1 (8.70%)

HRL

Hormel Foods

$33.31

-0.48 (-1.42%)

RCL

Royal Caribbean

$81.15

0.1 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 13

    Dec

  • 09

    Jan

RKDA

Arcadia Biosciences

, SEED

Origin Agritech

$2.50

0.02 (0.81%)

07:28
12/07/16
12/07
07:28
12/07/16
07:28
Conference/Events
UBS to hold a conference »

2016 UBS Agriculture Day…

RKDA

Arcadia Biosciences

SEED

Origin Agritech

$2.50

0.02 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

OSIS

OSI Systems

$76.45

0.51 (0.67%)

, ZIXI

ZixCorp

$4.45

0.03 (0.68%)

07:27
12/07/16
12/07
07:27
12/07/16
07:27
Conference/Events
Imperial Capital to hold a conference »

2016 Security Investor…

OSIS

OSI Systems

$76.45

0.51 (0.67%)

ZIXI

ZixCorp

$4.45

0.03 (0.68%)

APDN

Applied DNA Sciences

$2.25

0.05 (2.27%)

ASCMA

Ascent Capital

$18.00

-0.19 (-1.04%)

BCO

Brink's

$39.95

0.9 (2.30%)

CTRL

Control4

$11.20

0.01 (0.09%)

NSSC

NAPCO Security

$8.15

0.15 (1.88%)

VRNT

Verint

$38.20

0.15 (0.39%)

INVE

Identiv

$2.58

0.11 (4.45%)

QLYS

Qualys

$32.25

-0.25 (-0.77%)

TASR

TASER

$28.19

0.11 (0.39%)

PCTI

PCTEL

$5.06

0.09 (1.81%)

RDWR

Radware

$13.64

0.07 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

CGEN

Compugen

$6.10

0.1 (1.67%)

07:26
12/07/16
12/07
07:26
12/07/16
07:26
Hot Stocks
Compugen discloses cancer immunotherapy program for TIGIT »

Compugen disclosed today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CS

Credit Suisse

$14.69

1.01 (7.38%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Conference/Events
Credit Suisse to hold a conference »

2016 Quantitative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

EW

Edwards Lifesciences

$83.22

0.73 (0.88%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ARGS

Argos Therapeutics

$4.75

0.05 (1.06%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Conference/Events
Argos Therapeutics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

TCRD

THL Credit

$10.32

-0.02 (-0.19%)

, FSIC

FS Investment

$10.05

-0.05 (-0.50%)

07:24
12/07/16
12/07
07:24
12/07/16
07:24
Conference/Events
Wells Fargo to hold a forum »

2016 Middle Market…

TCRD

THL Credit

$10.32

-0.02 (-0.19%)

FSIC

FS Investment

$10.05

-0.05 (-0.50%)

BKCC

BlackRock Capital Investment

$7.41

0.08 (1.09%)

NMFC

New Mountain Finance

$14.20

-0.05 (-0.35%)

SLRC

Solar Capital

$20.67

0.14 (0.68%)

TCPC

TCP Capital

$16.95

-0.03 (-0.18%)

MAIN

Main Street

$36.37

-0.04 (-0.11%)

TSLX

TPG Specialty Lending

$18.49

0.12 (0.65%)

HTGC

Hercules Capital

$13.62

-0.12 (-0.87%)

KKR

KKR

$15.87

0.2 (1.28%)

TROW

T. Rowe Price

$76.09

0.51 (0.67%)

APO

Apollo Global

$19.28

0.03 (0.16%)

BX

Blackstone

$26.55

0.15 (0.57%)

GS

Goldman Sachs

$231.38

2.83 (1.24%)

WFC

Wells Fargo

$55.55

1.2 (2.21%)

ARCC

Ares Capital

$16.31

0.17 (1.05%)

MCC

Medley Capital

$7.63

-0.04 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 15

    Dec

WDC

Western Digital

$63.85

1.76 (2.83%)

07:24
12/07/16
12/07
07:24
12/07/16
07:24
Recommendations
Western Digital analyst commentary  »

Brean Capital ups Western…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LW

Lamb Weston

$33.82

0.17 (0.51%)

07:23
12/07/16
12/07
07:23
12/07/16
07:23
Recommendations
Lamb Weston analyst commentary  »

Lamb Weston should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FI

Frank's International

$12.51

-0.09 (-0.71%)

07:21
12/07/16
12/07
07:21
12/07/16
07:21
Syndicate
Breaking Syndicate news story on Frank's International »

Frank's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMO

Bank of Montreal

$69.33

1.85 (2.74%)

07:21
12/07/16
12/07
07:21
12/07/16
07:21
Upgrade
Bank of Montreal rating change  »

Bank of Montreal upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$57.92

0.64 (1.12%)

07:21
12/07/16
12/07
07:21
12/07/16
07:21
Periodicals
Citi says operations ran properly in sterling 'flash crash,' Reuters reports »

Citi said its trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 26

    Jan

EVHC

Envision Healthcare

$71.70

-0.05 (-0.07%)

07:20
12/07/16
12/07
07:20
12/07/16
07:20
Upgrade
Envision Healthcare rating change  »

Envision Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

07:20
12/07/16
12/07
07:20
12/07/16
07:20
General news
FX Update: The dollar settled at near net unchanged levels »

FX Update: The dollar…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.